# Ernexa Therapeutics Inc.: Form 8-K, filed Sep 16, 2026

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2026-09-16
- Accepted by EDGAR: Sep 16, 2026, 16:50 ET
- Period: 2026-09-14
- Accession: 0001493152-26-042934
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000149315226042934/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000149315226042934/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000149315226042934/form8-k.htm

Filed Sep 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-042934. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.